Open AccessLow efficacy of levofloxacin-doxycycline-based third-line triple therapy forHelicobacter pylorieradication in Italy
Author(s) -
Omero Alessandro Paoluzi,
Giovanna Del Vecchio Blanco,
Emanuela Visconti,
Manuela Coppola,
Carla Fontana,
Marco Favaro,
Francesco Pallone
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i21.6698
Subject(s) - levofloxacin , tolerability , helicobacter pylori , medicine , gastroenterology , doxycycline , esomeprazole , amoxicillin , clarithromycin , antibiotics , adverse effect , microbiology and biotechnology , biology
To evaluate a levofloxacin-doxycycline-based triple therapy with or without a susceptibility culture test in non-responders to Helicobacter pylori (H. pylori) eradication.